- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT03424434
Underreporting of Occupational Blood Exposure (OBE) Among Medical Staff at an University Hospital Center (UHC) in 2017 (OBE PRACTITIONERS UHC 2017)
Underreporting of Occupational Blood Exposure (OBE) Among Medical Staff at an University Hospital Center (UHC) in 2017
Studieoversikt
Studietype
Registrering (Faktiske)
Kontakter og plasseringer
Studiesteder
-
-
-
Clermont-Ferrand, Frankrike, 63003
- Chu Clermont-Ferrand
-
La Tronche, Frankrike, 38700
- Chu Grenoble Alpes
-
Pierre-Bénite, Frankrike, 69495
- Groupement Hospitalier Sud
-
Saint-Étienne, Frankrike, 42055
- Chu de Saint-Etienne
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Prøvetakingsmetode
Studiepopulasjon
Beskrivelse
Inclusion Criteria:
- Any medical or surgical health professional
- practitioner and resident
- working in an UHC
- without distinction of medical or surgical specialty
- having a professional mailbox
Exclusion Criteria:
- All paramedical health professionals (example: nurses) and pharmacists
- Any medical or surgical health professional working full-time outside an UHC
- Any medical or surgical health professional with exclusive liberal activity outside an UHC
- Administrative and technical staff of an UHC
Studieplan
Hvordan er studiet utformet?
Designdetaljer
Kohorter og intervensjoner
Gruppe / Kohort |
Intervensjon / Behandling |
|---|---|
|
Medical staff of an UHC, practitioners and residents
The target population is practitioners and residents who works at hospital in an UHC, they are also specialists, surgeons, dental surgeons.
|
The study consists in a survey diffusion during several weeks by emailing each practitioner and resident and inviting them to participate to a questionnaire about occupational blood exposure.
This survey is strictly anonymous.
No identity data is required, only age, gender, function, surgical or medical specialty, work quota and hospital group they belong.
This survey is diffused in four UHC (Lyon, Grenoble, Clermont-Ferrand and Saint-Etienne) in France.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Evaluation of underreporting occupational blood exposure (OBE) among the medical staff at an University Hospital Center (UHC) for the year 2017
Tidsramme: 1 day
|
This evaluation consists in collecting, during the diffusion of a survey, the number of OBE the medical professional is victim of and the number of OBE is reported to deduce the number of non-reported OBE, over the period of interest which is the year 2017.
|
1 day
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
The occurrence circumstances of OBE
Tidsramme: 1 day
|
These questions are gathered in a table and concern different sorts of contaminated needlesticks, blood projections, cut or wound and the positive serologic status for the source patient. This specific outcome is qualitatively evaluated with questions relating to the occurence circumstances of OBE with a choice of standards answers (Yes, always - Often - Sometimes - No, never). |
1 day
|
|
The part of each factor, related to the professional activity and to the OBE itself, in the OBE reporting.
Tidsramme: 1 day
|
Some questions are gathered in a table and propose 15 differents reasons that can condition the OBE reporting, such as lack of time, fear of judgment, repetition of OBE, unknowing of reporting procedure, lack of standards precautions, only antisepsis maneuvers sufficient, source patient considered as safe, procedure to report considered complex, fear of career consequences, lack of witness, night work, negatives serologies for the source patient, fear of the serological follow-up, fear observing an antiretroviral treatment, ignorance that an OBE was a true one. For each factor, a percentage will be measured as indicative of its importance in the OBE underreporting. This specific outcome considering various factors that can influence the reporting of an OBE is evaluated by several questions with a yes or no answer. |
1 day
|
|
Involvement of behaviors of underreporting medical professionals
Tidsramme: 1 day
|
Using two tables, several measures recommanded about the biological risk in hospital environment (including OBE) are discussed. These differents measures are considered as primary and secondary preventive behaviors. For each measure, we examine its frequency as indicative of its implication in the OBE underreporting. This outcome is evaluated with questions on vaccination, immunization, wearing of personal protective equipment and realization of the antisepsis maneuvers, realization of serologies for source patient and personal ones, with a choice of standards answers (Yes, always - Often - Sometimes - No, never). |
1 day
|
|
Practitioners knowledges about the specific infectious risk of OBE
Tidsramme: 1 day
|
On a first table, the participant has to choose one of the four rates proposed (30% - 1 to 3% - 0,3% - < 0,3%) to evaluate the risk of seroconversion after percutaneous contact with infected blood by HIV or hepatitis B virus (HBV) or hepatitis C virus (HCV). On a second table, the participant has to choose a time limit (Immediately - within 4 hours - within 48 hours - up to 7 days) for different situations near OBE occurence, it concerns antisepsis maneuvers, prophylactic antiretroviral treatment, initial personal serological status and source patient serological status. A test is proposed to evaluate knowledges about the infectious risk related to OBE, this test is optional, grouping together seven simple choice questions. |
1 day
|
Samarbeidspartnere og etterforskere
Sponsor
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Andre studie-ID-numre
- 69HCL17_0883
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .
Kliniske studier på Health Professional
-
Colgate PalmoliveFullførtOral Health LiteracyIndia
-
Alexandria UniversityRekrutteringMunnhygiene | Oral Health LiteracyEgypt
-
Foundation University IslamabadFullførtGamification in Health EducationPakistan
-
Forman Christian College, PakistanUNICEFRekrutteringMors helse | Maternal Health LiteracyPakistan
-
Zhongshan Ophthalmic Center, Sun Yat-sen UniversityFullførtVisual Health of Virtual RealityKina
-
Fernanda Muñoz SepúlvedaSubvención Presidencial, Ministerio de Hacienda, Chile; Centro Interuniversitario... og andre samarbeidspartnereFullførtMunnhelsekunnskap | Munnhelseholdninger | Oral Health Self-efficacyChile
-
University Hospital, GrenobleUkjentHealth Care Quality Management (ingen betingelse).Frankrike
-
Ari Johnson, MDHarvard Medical School (HMS and HSDM); University of California, San Francisco og andre samarbeidspartnereFullførtCommunity Health Worker Performance
-
University of Colorado, DenverEunice Kennedy Shriver National Institute of Child Health and Human Development... og andre samarbeidspartnereFullførtForebyggende helsetjenester (PREV HEALTH SERV)Forente stater
-
Seattle Children's HospitalEunice Kennedy Shriver National Institute of Child Health and Human Development... og andre samarbeidspartnereHar ikke rekruttert ennåForebyggende helsetjenester (PREV HEALTH SERV)Forente stater
Kliniske studier på Survey diffusion
-
Yale UniversityNational Institute on Drug Abuse (NIDA); APT Foundation, Inc.FullførtTobakksbruk | Sigarett røykingForente stater
-
Pennington Biomedical Research CenterMartin, Corby, K., M.D.FullførtErnæringsvitenskap | Klima | Resirkulering | AvfallshåndteringForente stater
-
Abramson Cancer Center at Penn MedicineConquer Cancer FoundationFullførtMage-tarmkreft | LungekreftForente stater
-
Medipol UniversityFullførtSlag | Bevisbasert praksis | FysioterapeutTyrkia (Türkiye)
-
University of NottinghamKing's College London; National Institute for Health Research, United KingdomRekrutteringFibrose | Artroplastikkkomplikasjoner | Kontraktur av kneleddStorbritannia
-
Children's Mercy Hospital Kansas CityRekrutteringImplementering av Spotlight AQ-plattformen hos ungdom/ung voksen (16–25 år) Type 1-diabetikere (T1D)Type 1 diabetes mellitusForente stater
-
Boston Medical CenterNational Heart, Lung, and Blood Institute (NHLBI)Fullført
-
Henry Ford Health SystemRekrutteringFor tidlig fødsel | Cervikal insuffisiens | Cervikal lengdemålingForente stater
-
Ceribell Inc.FullførtAnfall | Ikke-konvulsiv Status EpilepticusForente stater
-
Abramson Cancer Center at Penn MedicinePåmelding etter invitasjon